INTRODUCTION
The structure of the vessel wall includes a layer of contractile cells (vascular smooth muscle cells -VSMCin large vessels, pericytes in arterioles and venules), and the internal endothelium. The endothelium performs critical functions in the control of vessel wall permeability, by controlling exchanges via the transcellular and the paracellular routes [1] [2] [3] 4 . The paracellular route (based on destabilization of cell-to-cell endothelial junctions) is believed to be of primary importance for vessel hyperpermeability in pathophysiological situations 2, 5 . The endothelium also regulates contractile cell functions, by releasing vasorelaxing and vasoconstricting signals 6 , thereby regulating vessel tone and diameter, as well as blood pressure 7, 8 .
Vasodilatation, vascular hyperpermeability and plasma extravasation are hallmarks of inflammatory disorders, like allergic reactions (type I immediate hypersensitivity in the older nomenclature). In sensitized allergic individuals, the prevalent mechanism through which allergens trigger an inflammatory reaction is the activation of mast cells and basophils upon binding of multivalent antigen to Immunoglobulin (Ig)E-loaded high affinity IgE receptors, FcRI [9] [10] [11] [12] . Activated mast cells release preformed mediators such as histamine (also serotonin in rodents), proteases and neosynthetized arachidonic acid-derived prostaglandins and leukotrienes as well as cytokines, growth factors (like VEGF-A) and chemokines [13] [14] [15] [16] . Mediators such as histamine and VEGF-A decrease vessel tone and destabilize the endothelial barrier 5, 17 , causing systemic plasma extravasation and vasodilatation, which results in edema, decreased blood volume and hypotension 17, 18 . In its most severe form, systemic anaphylaxis, general vascular failure results is a life threatening altered tissue perfusion, which remains a major cause of lethality in systemic shocks 19, 20 . Surprisingly, while the importance of the vasculature in inflammation manifestations and allergies is widely acknowledged, therapeutic strategies targeting the vasculature in order to improve existing treatments have received little attention.
The three peroxisome proliferator-activated receptor (PPAR) isotypes PPAR, / and  are ligand-inducible transcription factors that form a subfamily of the nuclear hormone receptors 21 . The canonical pathway by which PPARs regulate gene transcription involves activation by an agonist, heterodimerization with the Retinoid X Receptor (RXR), binding to a PPAR response element (PPRE) in the promoter region of their target genes, and recruitment of coactivators, which results in the activation of the target genes. PPARs are activated by natural fatty acids and fatty acid derivatives 21-23 . Wawrzyniak 5 5 Importantly, PPAR and  are the therapeutic targets of fibrates, (lipid-lowering drugs), and thiazolidinediones (insulin-sensitizing compounds), respectively, although the use of thiazolidinediones has recently been restricted due to major side effects 24, 25 . PPAR/ is involved in the control of energy homeostasis, lipid metabolism, inflammation and skeletal and heart muscle functions 26, 27 , as well as in the development of the white adipose tissue, skin, gut and placenta [28] [29] [30] . We have identified PPAR/ as a key actor in skin repair 31, 32 and cancer 33 , and in the regulation of keratinocyte functions 32, 34, 35 . Recent results show that PPAR/ also regulates vasculature functions. In endothelial and/or vascular smooth muscle cells, PPAR/ performs pro-angiogenic, anti-inflammatory, anti-atherosclerotic and antihypertensive functions [36] [37] [38] [39] .
In this paper, we have shown that, whereas PPAR/ is dispensable for the development of mature microvessels, its activity is a key factor for acute vascular hyperpermeability (AVH) and vasodilatation. 6 6 METHODS Animals: Animal procedures were performed upon approval by the cantonal veterinary service of the Canton of Vaud or by the Ethical committee of the Nord-Pas-de Calais Region. PPARβ/ germline-deficient animals were described previously 30 . PPAR/ -/and control PPAR/ +/+ animals were littermates obtained from heterozygous mating.
An endothelial cell-specific PPAR/-deficient mouse line was obtained by crossing All mouse strains are maintained on a mixed C57BL6/SV29 background. Genotyping ( Figure E2 ; presence of the Cre recombinase transgene (472bp DNA fragment) of the PPAR/ invalidated allele (490bp DNA fragment), and of the PPAR/ floxed allele (400bp DNA fragment)) was performed by PCR of genomic DNA extracted from the ear (PCR positive control: Glut2 gene, 230bp DNA fragment). All animals were kept in a standard colony and in a temperature-and light-controlled environment, and were fed with a standard laboratory diet ad libitum.
Miles assay: Acute vascular permeability was assessed using the Miles assay. Evans blue dye (EBD; 100 µl, 5% solution in 0.9% NaCl) was injected in the tail vein of 6months old females. After 10 minutes, 50 ul of VEGF-A (PeproTech PEPR100-20D-10UG, 100 ng/ml), thrombin (Sigma-Aldrich AG T6884-100UN, 10 U/ml), histamine (Sigma-Aldrich AG H7125-1G, 100 µmole/l) or the control (PBS) were injected intradermally into the flank skin (PBS in the left side flank skin; vasoactive agents in the right side flank skin). After 30 minutes, the animals were euthanized, and full-thickness flank skin samples were collected (standardized 1 x 1cm surfaces, which included the 7 7 entire injection site), minced, and incubated in a fixed volume of 1 ml formamide for 48 hours at 60°C and extravasated EBD was quantified (OD 620 nm).
Anaphylaxis: Females (8-12 weeks old) were injected with 100µg/ml anti-DNP IgE (Sigma D 8406) or PBS (200µl per animal) intravenously (tail vein). 24 hours later, the anaphylaxis reaction was initiated by injection (i.v. tail vein) of 5mg/ml DNP-KLH (Calbiochem 324121-100MG) / 2% EBD (200µl). Hypothermia was monitored using an electronic thermometer with a rectal probe. At the end of the experiment (based on temperature recovery: 50 min for the PPARβ/ germline mouse strain, 100min for Tie1-PPARβ/ and SM22-PPARβ/ mouse strains), animals were euthanized and full thickness ear tissue samples (standardized surfaces with an 8 mm punch biopsy device) were collected, minced, and incubated in a fixed volume of 1 ml formamide, for 48 hours at 60°C) and extravasated EBD was quantified (OD 620 nm) 43, 44 .
Cell cultures and transfection: Human umbilical vein endothelial cells (HUVECs;
PromoCell C2519A; passages four to seven) were cultured in complete Endothelial Cell Growth Medium (PromoCell 211 0101). Cells were seeded in TPP plastic 6-well plates (0.1% gelatin coating), except for immunofluorescent stainings, for which cells were seeded on glass-bottom culture dishes (10ug/ml fibronectin coating). For siRNA transfection, 30-50% confluent HUVECs were treated with RNAimax (Life Tehnology 13778150) and 25nM control (Thermo Scientific, scrambled sequence) or PPARβ/ siRNA (PPAR/ loss-of-function; Thermo Scientific, GACCUGGCCCUAUUCAUUG). The number of ear dermal blood and lymph vessels (vessel density) was counted on three standardized, non adjacent, microscopic fields of 0.7 mm 2 . For the quantification of vessel dilatation, the surface occupied by the blood or lymph vessels (which reflects the vessel size) was quantified with computer-assisted morphometry (ImageJ software), standardized to the number of vessels and presented as a % of the total dermis surface subject to analysis. Three non-adjacent sections per animal, 6 animals per group, were analyzed. 9 9 Statistical analysis: Results were presented as mean values  standard deviation (SD) or standard error of mean (SEM) as indicated. Unless mentioned otherwise, the statistical comparison between groups was performed by using two-way ANOVA followed by Bonferroni`s multiple comparison test. Probability was considered to be significant at p < 0.05 (*** p<0.001, ** p<0.01, * p<0.05). For Figures 
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RESULTS
PPAR/ loss-of-function severely compromises acute vascular hyperpermeability (AVH) and microvessel dilatation in PPAR/ -/mice.
In order to evaluate the impact of PPAR/ on the development and maturation of the skin microvasculature, we compared dermal microvessels in PPAR/ -/and PPAR/ +/+ control animals. PPAR/ -/and PPAR/ +/+ animals had a similar dermal microvessel density ( Figure 1A ). Next, we examined the dermal microvessel wall architecture, which is expected to comprise a quiescent endothelium lined with a continuous basement membrane, covered by quiescent mural cells. Labeling with the Ki67 proliferation marker revealed no proliferating cells in the vessel wall of PPAR/ -/or PPAR/ +/+ skins, therefore confirming the absence of activated microvessels in the unchallenged tissues ( Figure 1B and E1A). Labeling with the collagen IV basement membrane marker showed that this layer was tightly surrounding the endothelium in a continuous manner in both PPAR/ -/and PPAR/ +/+ dermises, while detection of smooth muscle actin (SMA), a marker for vascular mural cells, revealed similar microvessel wrapping in PPAR/ -/and PPAR/ +/+ unchallenged dermises ( Figure   1B ). These observations were confirmed in whole mount staining of dermal vessels harvested from PPAR/ -/and PPAR/ +/+ mouse skin (data not shown).
In order to explore the role of PPAR/ in the acute increase of permeability and vasodilatation of the microvasculature, we induced an acute response by injecting VEGF-A in the dermis of PPAR/ -/and PPAR/ +/+ mice. We then quantified AVH as well as basal vessel permeability (BVP) with the Miles assay. In the unchallenged dermal microvessels, we observed no significant difference at the baseline between the PPAR/ -/and PPAR/ +/+ mice ( Figure 1C ). In response to the intradermal injection of VEGF-A, however, PPAR/ +/+ animals exhibited a 2.5 and 5 fold increase in AVH in the ear (data not shown) and the flank dermis ( Figure 1C ), respectively, compared to PBS injected controls. In contrast, VEGF-A injections failed to significantly stimulate microvessel AVH in the dermis of PPAR/ -/mice. This suggests that VEGF-A-induced dermal AVH is PPAR/-dependent ( Figure 1C ).
We further determined whether the lack of response of PPAR/ -/dermal vessels was specifically due to impaired VEGF-A signaling in the PPAR/ -/vessel wall by comparing the AVH response of PPAR/ -/and PPAR/ +/+ microvessels to the intradermal injection of two other well-characterized activators of vascular permeability, thrombin and histamine. Although thrombin is not involved in anaphylactic shocks, it was used as an independent vasoactive inflammatory mediator known to induce hyperpermeability 5 . Whereas PPAR/ +/+ dermal microvessels showed a significant increased in AVH in response to the dermal injection of VEGF-A (3 fold), thrombin (2.5 fold) and histamine (3.5 fold), PPAR/ -/dermal microvessels showed no significant AVH in response to any of the three vasoactive mediators ( Figure 1D ). Although lower expression levels of VEGFR-1 and 2 in the skin of PPAR/ -/may account for a lack of VEGF-A-induced AVH ( Figure E1C ), the absence of histamine and thrombin-induced AVH shows that the compromised response of the PPAR/ microvessels to vasoactive mediators is not limited to VEGF-A and involves more general mechanisms.
VEGF-A is also known to stimulate vasodilatation. We therefore investigated dermal microvessel enlargement in PPAR/ -/skin. Microvessel vasodilatation was quantified by computer-assisted morphometry on ear sections of PPAR/ -/and PPAR/ +/+ mice, following the intradermal injection of VEGF-A or vehicle (PBS), and labeling of the microvessels with the endothelial (CD31) and lymph endothelial (LYVE-1) markers ( Figure 1E ). In the PBS-injected dermis, no significant difference was observed in the number and size of the PPAR/ -/and PPAR/ +/+ blood vessels ( Figure 1E , left and middle panels) or lymph vessels ( Figure 1E , left and right panels). Upon stimulation with VEGF-A, PPAR/ +/+ mice displayed a significant 2.2 fold increase in blood dermal microvessel size, whereas PPAR/ -/blood dermal microvessels did not enlarge ( Figure 1E , left and middle panels). As expected in response to VEGF-A, lymph vessels, whose diameter is generally much more variable compared to blood vessels, remained unaffected in both PPAR/ -/and PPAR/ +/+ animals ( Figure 1E , left and right panels).
Overall, these data suggest that PPAR/ is dispensable for normal dermal vascularization, but is required for the acute response of dermal microvessels to vasoactive signals such as VEGF-A, histamine and thrombin.
Selective deletion of PPAR/ in endothelial cells is sufficient to compromise AVH and microvessel dilatation in Tie1-PPAR/ -/mice.
Next, we investigated the involvement of endothelial PPAR/ in the mediation of the The appropriate invalidation of the PPAR/ gene was evidenced in the dermis of Tie1-PPAR/ -/mice but not in the epidermis of these mice, neither in the Tie1-PPAR/ fl/fl dermis or epidermis, as expected for an endothelial-targeted inactivation ( Figure E2B ).
Furthermore, PPAR/ expression was decreased as expected in Tie1-PPAR/ -/thoracic aortas and total skin, the remaining PPAR/ expression levels being attributed to the non-endothelial cells of these tissues ( Figure E2C ). The density of dermal microvessels in the unchallenged skin of Tie1-PPAR/ -/animals was similar to that of the Tie1-PPAR/ fl/fl controls (Figure 2A ). In addition, the vessel wall was similar in animals of both genotypes, exhibiting quiescent endothelial and mural cell layers (Ki67), continuous lining of the endothelium with basement membrane (collagen IV) and similar wrapping with mural cells (SMA) ( Figure 2B ).
Then, we compared the acute response of skin dermal microvessels following VEGF-A These data show that the absence of PPAR/ in the vascular endothelium is sufficient to compromise the acute response of microvessels to VEGF-A exposure in Tie1-PPAR/ -/animals.
PPAR/ loss-of-function compromises the dynamics of the endothelial cell-tocell junction and the activity of kinases signaling pathways.
Since our data show that endothelial PPAR/ expression is a key factor for the stimulation of AVH, and since VEGF-A, histamine and thrombin are known to destabilize endothelial cell-to-cell junctions, thereby stimulating the paracellular permeability route, we examined whether PPAR/ might activate AVH by regulating endothelial paracellular permeability. We performed a siRNA-mediated PPAR/ knockdown in confluent human endothelial cells (HUVECs). PPAR/ siRNA reduced the PPAR/ mRNA level by 75% compared to scrambled control siRNA (Ctrl siRNA) ( Figure E3A ). The fact that no increase was observed in the expression of ANGTL-4 (a well-known PPAR/ target gene) in PPAR/ siRNA-transfected HUVECs, after treatment with a PPAR/ agonist, demonstrated that the transcriptional activity of PPAR/ was inhibited concomitantly with its decreased expression level ( Figure E3A ).
Neither the PPAR/ agonist treatment, nor the siRNA-mediated PPAR/ knockdown affected the expression levels of adherens junctions (AJ) proteins, i.e. VE-cadherin and associated -catenin, -catenin and p120-catenin ( Figure E3B ). However, the expression of one of the VEGF-A receptors was slightly decreased ( Figure E3C ).
Confluent HUVEC monolayers were then stimulated with VEGF-A, followed by VE- Figure 6A and B, Figure   E2D -F). This suggests that PPAR/ regulated IgE-mediated anaphylaxis through its expression on endothelial cells at least in part through control of their sensitivity/response to histamine.
DISCUSSION
PPAR/ is an important regulator of endothelial and smooth muscle cell activities.
PPAR/ supports angiogenesis in tumor growth and ischemia recovery [48] [49] [50] [51] , it displays anti-inflammatory and anti-atherogenic properties in EC and VSMC 36, 48, 52-57 , and PPAR/ agonists were reported to be vasorelaxing compounds 58, 59 able to reduce blood pressure and heart rate in spontaneously hypertensive rats 60 .
Despite this body of evidence in several pathophysiological conditions, PPAR/ involvement in vascular responses to the acute release of vasoactive mediators occurring in inflammation and allergies has not attracted any attention to date. Our work provides evidence that endothelial PPAR/ expression promotes local acute vasodilatation and AVH in response to allergic and inflammatory mediators. When exposed to such vasoactive mediators, the endothelium responds by increasing microvessel permeability to fluid, which provokes edema, and by releasing vasorelaxing agents, which relaxes VSMC and pericytes 7, 8 . In this paper, we have shown that endothelial-specific PPAR/ loss-of-function plays a protective role by reducing acute local vasodilatation and edema in response to VEGF-A and histamine.
This was not due to a lower expression of the VEGF or histamine receptors, which were expressed at similar, or even higher levels in the vena cava of PPAR/-deficient animals ( Figure E1B ). Although the exact mechanisms remain to be unveiled, the . It is to be noted that PPAR/ agonists were shown to indirectly restore NO bioavailability in vessels affected by chronic endothelial dysfunctions 71-74 .
Therefore, a possibility is that endothelial PPAR/ regulates acute vasodilatation via the regulation of NO and/or the prostacyclin release by endothelial cells. Importantly, proprietary software based on 45 ) software were used to analyze the data.
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Figure E4.
Histamine-induced hypothermia in Tie1-PPAR/ -/compared to Tie1-PPAR/ fl/fl mice.
Data are expressed as mean  SEM (n=4 for PBS injected animals; n= 5-7 for histamine injected animals).
